Ipsen names Mariette Finet to board, replacing Michèle Ollier
Ipsen co-opted Mariette Finet to its board, effective immediately, replacing Michèle Ollier, who resigned on Aug. 1. Finet, a physician, has 35+ years in healthcare, pharmaceuticals, and life sciences, including roles at Laboratoires Beaufour and Ipsen. She has advised Mayroy and Highrock since 2007 on investment analy